Diagnosis and treatment of pediatric Cushing's disease

Martin O Savage1, Helen L Storr, Li F Chan

  • 1Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK. m.o.savage@qmul.ac.uk

Pituitary
|June 16, 2007
PubMed

Insights

Cushing's disease (CD) in children is rare and challenging to diagnose and treat. Management requires specialized protocols and long-term follow-up for growth, bone health, and reproduction.

Area of Science:

  • Pediatric Endocrinology
  • Endocrinology
  • Rare Diseases

Background:

  • Cushing's disease (CD) is uncommon in pediatric patients, posing significant diagnostic and therapeutic challenges.
  • Pediatric endocrinologists often lack extensive experience with pediatric CD, necessitating collaboration with adult specialists.
  • Existing diagnostic and treatment protocols for adults can be adapted for pediatric cases.

Purpose of the Study:

  • To provide a comprehensive overview of diagnostic and therapeutic strategies for pediatric Cushing's disease.
  • To critically appraise current treatment options for children and adolescents with CD.
  • To highlight the long-term management challenges following cure in pediatric CD patients.

Main Methods:

  • Review and critical appraisal of existing literature on pediatric Cushing's disease.
  • Adaptation of adult diagnostic protocols for the pediatric population.
  • Analysis of treatment strategies and long-term outcomes.

Main Results:

  • Pediatric CD requires a diagnostic approach similar to adults, adapted for age.
  • Treatment strategies are discussed and critically evaluated for efficacy and safety in children.
  • Post-cure management is crucial for optimizing growth, bone health, reproduction, and body composition.

Conclusions:

  • Pediatric Cushing's disease management necessitates specialized protocols and multidisciplinary collaboration.
  • Effective long-term follow-up is essential to address growth, bone, reproductive, and body composition issues in pediatric CD survivors.

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...